OncoStars is back! Panacea Stars — Cancer Research UK partnership is calling all cancer researchers working on cutting-edge oncology-based innovations.

Panacea renews its partnership with Cancer Research UK, the world’s largest funder of cancer research, to help young entrepreneurs form, develop and grow ground-breaking ideas in the field of oncology.

This partnership is part of the Cancer Research UK Entrepreneurial Programmes Initiative which aims to promote and enable cancer researchers to engage in entrepreneurship to translate their ideas and discoveries into patient benefit.

OncoStars invites scientists to think about their research from a translational perspective, to awaken their entrepreneurial need for action, and to make those first steps on the journey of building a start-up around their bold visions.

The partnership works on establishing the next generation of ventures that bring market-leading solutions within the areas of: therapeutics, medtech, diagnostics, digital health, AI and platform technologies. The OncoStars programme provides scientists and entrepreneurs with top-tier support, education, resources and access to investors.

Mina Bekheet, Panacea’s CEO and Founder commented:

“We are proud and privileged to be working so closely with Cancer Research UK. We are looking forward to seeing the benefit for all scientists within the oncology domain and likewise, for cancer patients, arising through this collaboration. The experience, resources and leading role of Cancer Research UK, combined with our novel model, capital and ever-growing network of strong partners will help to support researchers in translating their science into tangible products and services.”

Tony Hickson, Cancer Research UK’s Chief Business Officer, said:

“We are delighted to partner with Panacea Stars to launch another round of the OncoStars programme which continues to inspire a new generation of scientific entrepreneurs and support venture creation. Helping scientists translate their research out of the lab is critical for bringing new technologies and treatments into the clinic, shaping the future of how we diagnose, treat and screen people with cancer.”

As part of the OncoStars programme, Panacea and Cancer Research UK will be co-hosting a multi-phased framework, joined by seasoned experts, to further explore the translation of science from the lab into the clinic to ensure the greatest impact.

The application call for the OncoStars Action programme, dedicated to ideas/start-ups based around oncology is open now. Applicants shortlisted for the programme will gain business and entrepreneurial training along with access to Cancer Research UK’s and Panacea’s professional networks. The top teams will subsequently get the opportunity to join the wider Panacea Stars Develop and Grow phases, where they will receive tailored support and resources, and the opportunity to receive capital. The programme is enabling the founders to de-risk their start-up, build their proof of concept and turn their idea into a thriving business which will help to diagnose, treat or prevent cancer.

You can learn more about the partnership and apply for the programme here: https://panacea-stars.com/projects/oncostars/

OXFORD/LONDON — UNITED KINGDOM — THURSDAY 04th MARCH, 2021

Notes for editors:

About Panacea

Panacea Innovation is a science and technology translation ecosystem. Panacea Stars is Panacea’s flagship health and life sciences translation platform. We collaborate with the most exciting sci-entrepreneurs to help transform bold visions into thriving companies that improve people’s lives. Whether they have the seed of a scientific innovation or a well-developed proof-of-concept, our multi-phase framework is designed to help translate their bold ideas into a successful business. Visit www.panacea-stars.com.

About Cancer Research UK’s Commercial Partnerships Team

Our specialist Commercial Partnerships Team works with leading international cancer scientists and their institutes to protect intellectual property arising from their research and to establish links with commercial partners. The team develops promising ideas into successful cancer therapeutics, software, devices, diagnostics and enabling technologies. This helps to accelerate progress in exciting new discoveries in cancer research and bring new treatments to patients sooner. Visit http://commercial.cancerresearchuk.org/

About Cancer Research UK

• Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research.
• Cancer Research UK’s pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
• Cancer Research UK receives no funding from the UK government for its life-saving research. Every step it makes towards beating cancer relies on vital donations from the public.
• Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last 40 years.
• Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK’s ambition is to accelerate progress so that by 2034, 3 in 4 people will survive their cancer for at least 10 years.
• Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
• Together with its partners and supporters, Cancer Research UK’s vision is to bring forward the day when all cancers are cured.

For further information about Cancer Research UK’s work or to find out how to support the charity, please call 0300 123 1022 or visit www.cancerresearchuk.org. Follow us on Twitter and Facebook.